Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Editor's Pick
Protesters in Brussels participate in the Walk for Your Future climate march ahead of COP27. United Nations climate conferences typically reach their peak just...
Editor's Pick
In Risky Business: Why Insurance Markets Fail and What to Do About It (Yale University Press, 2023), economists Liran Einav (Stanford), Amy Finkelstein (MIT),...
Editor's Pick
Entrepreneurs are transforming the way society makes and distributes valuable things. There will be (and already are) important consequences for the way we work...
Editor's Pick
For years the North Korean playbook was obvious to the world. The Democratic People’s Republic of Korea wanted to be the center of attention....